{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:14:42Z","timestamp":1790813682432,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nano.2019.102140","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T21:27:45Z","timestamp":1575926865000},"page":"102140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment"],"prefix":"10.1016","volume":"24","author":[{"given":"Amit","family":"Badihi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Fru\u0161i\u0107-Zlotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Soroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Benhamron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Tzur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Benita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nano.2019.102140_bb0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2015012114","article-title":"Atopic dermatitis: drug delivery approaches in disease management","volume":"32","author":"Lalan","year":"2015","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"2","key":"10.1016\/j.nano.2019.102140_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1468-3083.2009.03358.x","article-title":"Topical corticosteroids in psoriasis: strategies for improving safety","volume":"24","author":"Horn","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"1","key":"10.1016\/j.nano.2019.102140_bb0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.nano.2019.102140_bb0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2013.07.049","article-title":"Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review","volume":"133","author":"Roekevisch","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.nano.2019.102140_bb0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.02.062","article-title":"The use of cyclosporine in dermatology: part II","volume":"63","author":"Ryan","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.nano.2019.102140_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0923-1811(00)00166-3","article-title":"Relationship between lymphocyte cyclosporin sensitivity and clinical progress of psoriasis","volume":"26","author":"Umezawa","year":"2001","journal-title":"J Dermatol Sci"},{"issue":"5","key":"10.1016\/j.nano.2019.102140_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/03639040500529168","article-title":"Bicontinuous water-AOT\/Tween85-isopropyl myristate microemulsion: a new vehicle for transdermal delivery of cyclosporin A","volume":"32","author":"Liu","year":"2006","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.nano.2019.102140_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2004.12.003","article-title":"Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer","volume":"60","author":"Lopes","year":"2005","journal-title":"European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV"},{"issue":"12","key":"10.1016\/j.nano.2019.102140_bb0045","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/exd.12051","article-title":"Penetration and biological effects of topically applied cyclosporin A nanoparticles in a human skin organ culture inflammatory model","volume":"21","author":"Frusic-Zlotkin","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.nano.2019.102140_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2014.09.021","article-title":"Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways","volume":"196","author":"Lapteva","year":"2014","journal-title":"Journal of controlled release : official journal of the Controlled Release Society."},{"issue":"3","key":"10.1016\/j.nano.2019.102140_bb0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jconrel.2011.07.022","article-title":"Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression","volume":"156","author":"Holan","year":"2011","journal-title":"Journal of controlled release : official journal of the Controlled Release Society."},{"key":"10.1016\/j.nano.2019.102140_bb0060","first-page":"190","article-title":"Topical delivery of cyclosporine A into the skin using SPACE-peptide","volume":"199C","author":"Chen","year":"2014","journal-title":"Journal of controlled release : official journal of the Controlled Release Society."},{"key":"10.1016\/j.nano.2019.102140_bb0065","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.2147\/IJN.S125302","article-title":"Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action","volume":"12","author":"Musa","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2019.102140_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2014.06.019","article-title":"Enhanced cutaneous bioavailability of dehydroepiandrosterone mediated by nano-encapsulation","volume":"189","author":"Badihi","year":"2014","journal-title":"Journal of controlled release : official journal of the Controlled Release Society."},{"issue":"4","key":"10.1016\/j.nano.2019.102140_bb0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.intimp.2010.01.001","article-title":"A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis","volume":"10","author":"Lehto","year":"2010","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10.1016\/j.nano.2019.102140_bb0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1600-0625.2011.01317.x","article-title":"Skin organ culture as a model to study oxidative stress, inflammation and structural alterations associated with UVB-induced photodamage","volume":"20","author":"Portugal-Cohen","year":"2011","journal-title":"Exp Dermatol"},{"issue":"7","key":"10.1016\/j.nano.2019.102140_bb0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00011-012-0465-3","article-title":"Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin","volume":"61","author":"Yehuda","year":"2012","journal-title":"Inflamm Res"},{"issue":"8","key":"10.1016\/j.nano.2019.102140_bb0090","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI1647","article-title":"Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice","volume":"101","author":"Spergel","year":"1998","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.nano.2019.102140_bb0095","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.4049\/jimmunol.165.12.6783","article-title":"CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity","volume":"165","author":"Wang","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.nano.2019.102140_bb0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.1990.tb01480.x","article-title":"Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity","volume":"123","author":"Duncan","year":"1990","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.nano.2019.102140_bb0105","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/81359","article-title":"Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation","volume":"6","author":"Rothbard","year":"2000","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.nano.2019.102140_bb0110","first-page":"332","article-title":"Treatment of alopecia areata in the DEBR model using cyclosporin A lipid vesicles","volume":"14","author":"Verma","year":"2004","journal-title":"Eur J Dermatol"},{"issue":"7","key":"10.1016\/j.nano.2019.102140_bb0115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamadermatol.2016.0859","article-title":"Sharma, et al. Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis: a randomized clinical trial","volume":"152","author":"Kumar","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.nano.2019.102140_bb0120","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int J Phar"},{"issue":"1\u20132","key":"10.1016\/j.nano.2019.102140_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2018.04.049","article-title":"Development of microemulsions of suitable viscosity for cyclosporine skin delivery","volume":"545","author":"Benigni","year":"2018","journal-title":"Int J Pharm"},{"issue":"Suppl 36","key":"10.1016\/j.nano.2019.102140_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2133.1990.tb02886.x","article-title":"Predictive value of cyclosporin A level for efficacy or renal dysfunction in psoriasis","volume":"122","author":"Feutren","year":"1990","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.nano.2019.102140_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nano.2019.102140_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2885.2004.00587.x","article-title":"Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs","volume":"27","author":"Steffan","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.nano.2019.102140_bb0145","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00007691-199610000-00004","article-title":"Blood concentrations and clinical effect of cyclosporin in psoriasis","volume":"18","author":"Furlanut","year":"1996","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.nano.2019.102140_bb0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/1523-1747.ep12464387","article-title":"Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media","volume":"91","author":"Fisher","year":"1988","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.nano.2019.102140_bb0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbrc.2006.11.135","article-title":"Targeting of nanoparticles to the clathrin-mediated endocytic pathway","volume":"353","author":"Harush-Frenkel","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2019.102140_bb0160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2015.12.010","article-title":"Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects","volume":"223","author":"Mathes","year":"2016","journal-title":"Journal of controlled release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.nano.2019.102140_bb0165","doi-asserted-by":"crossref","unstructured":"Christmann R, Thomas C, Jager N, Raber AS, Loretz B, Schaefer UF, et al. Nanoparticle targeting to scalp hair follicles \u2014 new perspectives for a topical therapy of alopecia areata. The Journal of investigative dermatology. 2019.","DOI":"10.1016\/j.jid.2019.05.028"},{"issue":"12","key":"10.1016\/j.nano.2019.102140_bb0170","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.4049\/jimmunol.175.12.8320","article-title":"Topical superantigen exposure induces epidermal accumulation of CD8+ T cells, a mixed Th1\/Th2-type dermatitis and vigorous production of IgE antibodies in the murine model of atopic dermatitis","volume":"175","author":"Savinko","year":"2005","journal-title":"J Immunol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419302242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419302242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:13:01Z","timestamp":1761549181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419302242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":34,"alternative-id":["S1549963419302242"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2019.102140","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2019.102140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102140"}}